SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

Background SLE is a chronic autoimmune disease with heterogeneous manifestations and variable outcomes. Geographic factors ...

When people with systemic lupus erythematosus (SLE) actively participate in shared decision-making (SDM) about their disease with their doctors’, trust is likely to increase. A new study found that ...

A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...

SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

Please provide your email address to receive an email when new articles are posted on . The acceptable threshold for glucocorticoid use for lupus maintenance therapy should be 5 mg per day prednisone ...

The SLECRISK tool for predicting cardiovascular disease among patients with systemic lupus erythematosus produces more accurate predictions compared with the American College of Cardiology/American ...

The new EULAR recommendations were developed by a multidisciplinary task force of patient research partners, nurses, and health care professionals from rheumatology as well as experts in physiotherapy ...

The report suggests childcare concerns could be a significant factor keeping Black women from attending weekly workshops. A new report finds younger Black women with systemic lupus erythematosus (SLE) ...